ArticleCell reports. Medicine2026

Inhibition of MAPK p38α overcomes the cancer immunosurveillance defect caused by FPR1 loss-of-function mutation.

Yuhong Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.